Related Experiment Video
Updated: Aug 24, 2025

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
Published on: September 20, 2015
Imaging Technologies for Cerebral Pharmacokinetic Studies: Progress and Perspectives.
Weikang Ban1, Yuyang You2, Zhihong Yang1
1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
Non-invasive imaging techniques enable accurate assessment of drug behavior within the brain, improving predictions of drug effects and toxicity. This enhances central nervous system drug development by overcoming the blood-brain barrier challenges.
Area of Science:
- Pharmacology
- Neuroscience
- Drug Development
Background:
- The blood-brain barrier (BBB) restricts drug entry into the central nervous system (CNS), complicating drug development by creating a disconnect between blood and brain drug concentrations.
- Drugs not intended for CNS action can cause adverse effects when they reach brain tissue, necessitating specialized pharmacokinetic studies.
- Intracerebral pharmacokinetic studies are essential for understanding drug disposition and action within the brain.
Purpose of the Study:
- To review the evolution and application of imaging technologies for cerebral pharmacokinetic studies.
- To evaluate the advantages and limitations of various imaging methods for predicting drug pharmacodynamics and toxicity in brain tissues.
- To highlight how advanced imaging enhances the reliability of intracerebral pharmacokinetics.
Main Methods:
- Development of intracerebral pharmacokinetic studies to assess drug disposition after brain absorption.
- Advancement of cerebral pharmacokinetic techniques into non-invasive imaging methods.
- Application of optical imaging, radiographic autoradiography, radionuclide imaging, and mass spectrometry imaging for molecular tracking across the BBB.
Main Results:
- Non-invasive imaging allows visualization of molecule entry into the BBB and provides reliable pharmacokinetic profiles when combined with quantitative tools.
- Imaging-based techniques have significantly advanced intracerebral pharmacokinetics, making it more complete and dependable.
- These methods facilitate the elucidation of drug action dynamics and prediction of drug courses within the brain.
Conclusions:
- Imaging technologies are crucial for accurate cerebral pharmacokinetic assessment.
- These techniques improve the prediction of pharmacodynamic and toxic effects of drugs in brain tissues.
- The advancement in imaging offers a more reliable pathway for CNS drug development and safety evaluation.
More Related Videos
08:36Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
Published on: June 7, 2024
10:31Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG
Published on: December 28, 2014
Related Concept Videos
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET